The Pharmaceutical Innovation & Invention Index seeks to answer the provocative question, ‘If two pharma companies were given the same molecule in early phase, which of the two would be better in developing and launching it?”
Released for the first time in 2019 and now in its sixth year, the Pharmaceutical Invention Index examines pipeline invention and novelty by taking a focused look at the breadth and depth of novel agents currently being developed within the top 30 pharma pipelines. The Invention Index provides a more forward-looking view of who is developing medicines that matter, embracing science and innovations in R&D.
See the full results and download the report here
Subscribe to our newsletter for more insights.
Further reading
-
Industry
Despite / because of...
Despite the challenges, she succeeded in her career. Because of the challenges, she succeeded in her career.
-
Announcement
IDEA Pharma and Exploristics partnership
IDEA PHARMA AND EXPLORISTICS ANNOUNCE STRATEGIC PARTNERSHIP TO ENHANCE PATH-TO-MARKET STRATEGIES FOR BIOPHARMA BY IMPROVING CLINICAL PROBABILITY OF SUCCESS AND COMMERCIAL OUTCOMES
